Microbot Medical Secures Design Patent Grant in Europe for the LIBERTY® Robotic System
HINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Demonstrating another key achievement, Microbot Medical Inc. (Nasdaq: MBOT), continues to execute...
HINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Demonstrating another key achievement, Microbot Medical Inc. (Nasdaq: MBOT), continues to execute...
BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading...
HAUPPAUGE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...
DALLAS, Aug. 31, 2022 (GLOBE NEWSWIRE) -- International Esperanza Project (IEP), a Dallas-based nonprofit whose mission is to inspire hope...
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 26 August 2022 – 8AM CET Disclosure of received notification from The Goldman Sachs Group,...
ALLEN, Texas, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation. (NASDAQ: ATRI) today announced that its Board of Directors has...
MURRAY, Utah, Aug. 25, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), announced today a 10-year partnership with...
Expanding services and offerings to the infectious disease community throughout the U.S. provides revenue growth opportunityServices at launch include rapid...
DEERFIELD, Ill., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on...
2022-08-24 PRESSRELEASE Arcoma receives order of 8 systems to Thailand Arcoma AB has received an order of 8 X-ray systems...
This partnership brings eSight 4 availability to 1,298 VA centers nationwideTORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform,...
SAN LEANDRO, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in...
Initial focus of five-year collaboration will be on potentially best-in-class ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601, which together comprise...
Natural Health Science Foundation Assessment Further Verifies Tilray Medical’s High-Quality Standard and its CBD100 Product for Clinical Trial UseSYDNEY, Australia,...
Former Medicine Development Leader for MAGE-A4+ Autologous Cell Therapies Will Support Advancement of CDR-Life’s M-gager® Solid Tumor TherapiesZÜRICH, Switzerland, Aug....
Oslo, August 19, 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces its second...
Capital raise comes amid rapidly growing demand for the company’s HIPAA compliant email and marketing solutionsSAN FRANCISCO, Aug. 18, 2022...
Polish Ministry of Health Approves Tilray Branded Medical Cannabis for Pharmaceutical Distribution in Addition to Wholesale ApprovalLEAMINGTON, Ontario and CANTANHEDE,...
For the second year in a row, the VR company is recognized as one of the nation’s fastest-growing private companiesBOSTON,...
HAUPPAUGE, N.Y., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on...